2021
DOI: 10.1080/10826076.2021.1979582
|View full text |Cite
|
Sign up to set email alerts
|

Size exclusion chromatography for the characterization and quality control of biologics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 159 publications
0
1
0
Order By: Relevance
“…With its mild chromatographic conditions, SEC permits the analysis of biologic drugs with minimal impact on the conformational structure and local environment of a molecule. Thus, it is used in the manufacturing process to guide the cell-line selection and development of the purification process, formulation development, routine analysis of aggregation of biotherapeutic proteins, and stability studies (6). It is included in the list of the typically used tests in the European Pharmacopoeia guidance document entitled ''Technical Guide for the Elaboration of Monographs on Synthetic Peptides and Recombinant DNA Proteins" (7).…”
Section: Introductionmentioning
confidence: 99%
“…With its mild chromatographic conditions, SEC permits the analysis of biologic drugs with minimal impact on the conformational structure and local environment of a molecule. Thus, it is used in the manufacturing process to guide the cell-line selection and development of the purification process, formulation development, routine analysis of aggregation of biotherapeutic proteins, and stability studies (6). It is included in the list of the typically used tests in the European Pharmacopoeia guidance document entitled ''Technical Guide for the Elaboration of Monographs on Synthetic Peptides and Recombinant DNA Proteins" (7).…”
Section: Introductionmentioning
confidence: 99%